BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30903708)

  • 1. Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats.
    Xia H; He Q; Wang H; Wang Y; Yang Y; Li Y; Zhang J; Chen Z; Yang J
    Fundam Clin Pharmacol; 2019 Oct; 33(5):535-543. PubMed ID: 30903708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-lipoxygenase activation is involved in the mechanisms of chronic hepatic injury in a rat model of chronic aluminum overload exposure.
    Mai S; He Q; Wang H; Hu X; Luo Y; Yang Y; Kuang S; Tian X; Ma J; Yang J
    Toxicol Appl Pharmacol; 2016 Aug; 305():259-266. PubMed ID: 27368151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protection of meloxicam against chronic aluminium overload-induced liver injury in rats.
    Yang Y; He Q; Wang H; Hu X; Luo Y; Liang G; Kuang S; Mai S; Ma J; Tian X; Chen Q; Yang J
    Oncotarget; 2017 Apr; 8(14):23448-23458. PubMed ID: 28423583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of meloxicam on aluminum overload-induced cerebral damage in mice.
    Jun-Qing Y; Bei-Zhong L; Bai-Cheng H; Qi-Qin Z
    Eur J Pharmacol; 2006 Oct; 547(1-3):52-8. PubMed ID: 16928369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.
    Polito F; Bitto A; Irrera N; Squadrito F; Fazzari C; Minutoli L; Altavilla D
    Br J Pharmacol; 2010 Nov; 161(5):1002-11. PubMed ID: 20977452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation.
    Liu Y; Duan C; Chen H; Wang C; Liu X; Qiu M; Tang H; Zhang F; Zhou X; Yang J
    Toxicol Appl Pharmacol; 2018 Jul; 351():1-11. PubMed ID: 29763636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mouse brain from aluminum-induced damage by caffeic acid.
    Yang JQ; Zhou QX; Liu BZ; He BC
    CNS Neurosci Ther; 2008; 14(1):10-6. PubMed ID: 18482095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin Exerts the Hepatoprotection from Chronic Alcohol-Induced Liver Injury via Inhibiting the Cyclooxygenase-2 and the 5-Lipoxygenase Pathway in Rats.
    Tian L; Fan F; Zheng S; Tong Q
    Complement Med Res; 2021; 28(2):104-113. PubMed ID: 32720917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
    Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
    Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
    Li CT; Zhang WP; Lu YB; Fang SH; Yuan YM; Qi LL; Zhang LH; Huang XJ; Zhang L; Chen Z; Wei EQ
    J Neurosci Res; 2009 Mar; 87(4):991-1001. PubMed ID: 18951527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma.
    Shi HY; Lv FJ; Zhu ST; Wang QG; Zhang ST
    Cancer Lett; 2011 Oct; 309(1):19-26. PubMed ID: 21652147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Caffeic Acid on Ischemia-Reperfusion-Induced Acute Renal Failure in Rats.
    Kinra M; Arora D; Mudgal J; Pai KSR; Mallikarjuna Rao C; Nampoothiri M
    Pharmacology; 2019; 103(5-6):315-319. PubMed ID: 30870859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Neurosci Bull; 2009 Dec; 25(6):343-52. PubMed ID: 19927170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal Ion Imbalance-Related Oxidative Stress Is Involved in the Mechanisms of Liver Injury in a Rat Model of Chronic Aluminum Exposure.
    Yang Y; Wang H; Guo Y; Lei W; Wang J; Hu X; Yang J; He Q
    Biol Trace Elem Res; 2016 Sep; 173(1):126-31. PubMed ID: 26811106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of anandamide in the hepatic microcirculation in cirrhotic rats.
    Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G328-34. PubMed ID: 16407591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
    Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.